These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 35395130)

  • 1. Hepatitis C screening during SARS-CoV-2 testing or vaccination. Experience in an area of southern Italy in the province of Salerno.
    Torre P; Annunziata M; Sciorio R; Coppola C; Masarone M; Persico M
    Liver Int; 2022 Jun; 42(6):1467-1469. PubMed ID: 35395130
    [No Abstract]   [Full Text] [Related]  

  • 2. Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: A cohort study.
    Coppola C; Masarone M; Bartoli M; Staiano L; Coppola R; Torre P; Conforti M; Amoruso D; Gardini I; Persico M
    J Viral Hepat; 2022 Feb; 29(2):171-173. PubMed ID: 34585821
    [No Abstract]   [Full Text] [Related]  

  • 3. Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world.
    Crespo J; Lazarus JV; Iruzubieta P; García F; García-Samaniego J;
    J Hepatol; 2021 Jul; 75(1):224-226. PubMed ID: 33757805
    [No Abstract]   [Full Text] [Related]  

  • 4. Detecting HCV infection by means of mass population SARS-CoV-2 screening: A pilot experience in Northern Italy.
    Giacomelli A; Pagani G; Conti F; Bassoli C; Galli M
    J Hepatol; 2021 Aug; 75(2):484-486. PubMed ID: 33453329
    [No Abstract]   [Full Text] [Related]  

  • 5. HCV detection is possible during SARS CoV-2 testing; and throughout COVID-19 vaccination?
    Crespo J; Díaz-González Á; Cabezas J
    J Hepatol; 2021 Aug; 75(2):486-487. PubMed ID: 33971225
    [No Abstract]   [Full Text] [Related]  

  • 6. HCV point of care screening in people tested for SARS-CoV-2 in a social-housing neighbourhood of Milan, Italy.
    Beltrami M; Pagani G; Conti F; Pezzati L; Casalini G; Rondanin R; Prina A; Zagari A; Galli M; Giacomelli A
    Liver Int; 2023 Jan; 43(1):251-255. PubMed ID: 35869660
    [No Abstract]   [Full Text] [Related]  

  • 7. SARS-CoV-2 massive testing: A window of opportunity to catch up with HCV elimination.
    Crespo J; Díaz-González Á; Iruzubieta P; Llerena S; Cabezas J
    J Hepatol; 2021 Apr; 74(4):966-967. PubMed ID: 33039405
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?
    do Carmo RF; de Souza CDF
    J Hepatol; 2022 Feb; 76(2):470-472. PubMed ID: 34437907
    [No Abstract]   [Full Text] [Related]  

  • 9. Are people previously infected with SARS-CoV-2 likely to experience COVID-19 symptoms again after vaccination? Results from an Italian COVID-19 referral center.
    Colaneri M; Di Benedetto A; Marvulli LN; Bocchio F; Cutti S; Marena C; Calvi M; Bruno R
    Hum Vaccin Immunother; 2022 Dec; 18(1):1920273. PubMed ID: 34114927
    [No Abstract]   [Full Text] [Related]  

  • 10. Leveraging corona virus disease 2019 vaccination to promote hepatitis C screening: Erratum.
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972384
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical characteristics of SARS-CoV-2 fully-vaccinated patients dying with COVID-19 in Italy.
    Palmieri L; Floridia M; Giuliano M; Tiple D; Lo Noce C; Meli P; Onder G;
    Clin Microbiol Infect; 2022 Jun; 28(6):890-892. PubMed ID: 35181537
    [No Abstract]   [Full Text] [Related]  

  • 12. Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey.
    Crispino F; Brinch D; Carrozza L; Cappello M
    Inflamm Bowel Dis; 2021 Oct; 27(11):e134-e135. PubMed ID: 34089256
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
    Fabiani M; Puopolo M; Morciano C; Spuri M; Spila Alegiani S; Filia A; D'Ancona F; Del Manso M; Riccardo F; Tallon M; Proietti V; Sacco C; Massari M; Da Cas R; Mateo-Urdiales A; Siddu A; Battilomo S; Bella A; Palamara AT; Popoli P; Brusaferro S; Rezza G; Menniti Ippolito F; Pezzotti P;
    BMJ; 2022 Feb; 376():e069052. PubMed ID: 35144968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of SARS-CoV-2 (Covid-19) in Italians and in immigrants in an area of Northern Italy (Reggio Emilia).
    Reggio Emilia Covid-19 Working Group
    Epidemiol Prev; 2020; 44(4):304-307. PubMed ID: 32921037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered hepatitis C testing and treatment beyond the COVID-19 pandemic.
    Karimi-Sari H; Rezaee-Zavareh MS
    Public Health; 2022 Jun; 207():e5. PubMed ID: 35568527
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on the status of COVID-19 vaccination in Italy-April 2023.
    Mattiuzzi C; Lippi G
    Immunol Res; 2023 Oct; 71(5):671-672. PubMed ID: 37079219
    [No Abstract]   [Full Text] [Related]  

  • 17. Seasonality of COVID-19 deaths. Did social restrictions and vaccination actually impact the official reported dynamic of COVID-19 pandemic in Italy?
    Chirumbolo S; Pandolfi S; Valdenassi L
    Environ Res; 2022 Sep; 212(Pt B):113229. PubMed ID: 35405125
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness.
    Monin MB; Marx B; Meffert L; Boesecke C; Rockstroh JK; Strassburg CP; Brossart P; Heine A
    Ann Hematol; 2022 Sep; 101(9):2089-2090. PubMed ID: 35608678
    [No Abstract]   [Full Text] [Related]  

  • 19. The university as a safe environment during the SARS-COV-2 pandemic: the experience of Bari Politecnico.
    Cupertino F; Spataro S; Spinelli G; Schirinzi A; Bianchi FP; Stefanizzi P; Di Serio F; Tafuri S
    Ann Ig; 2021; 33(2):201-202. PubMed ID: 33570091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution.
    Baj A; Novazzi F; Genoni A; Ferrante FD; Taborelli S; Pini B; Partenope M; Valli M; Gasperina DD; Capuano R; Prestia M; Spezia PG; Azzi L; Focosi D; Maggi F
    Emerg Microbes Infect; 2021 Dec; 10(1):1254-1256. PubMed ID: 34110974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.